Detalhe da pesquisa
1.
Polypill Strategy in Secondary Cardiovascular Prevention.
N Engl J Med
; 387(11): 967-977, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018037
2.
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study.
Cardiovasc Diabetol
; 21(1): 162, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999556
3.
Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction.
Cardiovasc Diabetol
; 21(1): 223, 2022 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309742
4.
Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
Diabetes Obes Metab
; 24(5): 891-898, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014746
5.
UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?
J Intern Med
; 295(1): 110-112, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592407
6.
Prevalence and Predictors of Post-Acute COVID-19 Symptoms in Italian Primary Care Patients.
J Prim Care Community Health
; 15: 21501319231222364, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166461
7.
Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
Drugs Aging
; 41(3): 239-249, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38367169
8.
Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy.
Diabetes Res Clin Pract
; 202: 110742, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270072
9.
Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes.
Clin Ther
; 45(4): e115-e126, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933975
10.
Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy.
Front Cardiovasc Med
; 10: 1244002, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781303
11.
Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study.
Eur Heart J Cardiovasc Pharmacother
; 7(FI1): f84-f92, 2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129845
12.
The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
Eur J Intern Med
; 99: 121-123, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35067414
13.
Effectiveness and safety of high and low dose NOACs in patients with atrial fibrillation.
Eur J Intern Med
; 88: 118-122, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612349